Ethics of clinical trials from bayesian perspective: Society's role is important

BMJ

Volumn 326, Issue 7404, 2003, Pages 1456-1457

  Senn, Stephen J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; CANCER CHEMOTHERAPY; CANCER SURVIVAL; HUMAN; LETTER; MALE; MEDICAL ETHICS; PATIENT ATTITUDE; PEER REVIEW; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; DECISION MAKING; ETHICS; NOTE; PATIENT PARTICIPATION; PATIENT RIGHT;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CLINICAL TRIALS; DECISION MAKING; HUMANS; PATIENT PARTICIPATION; PATIENT RIGHTS;

EID: 0344272289     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.326.7404.1456-b     Document Type: Letter

References (5)

1. Lilford RJ. Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway? BMJ 2003; 326: 980–1. (3 May.)
2. Senn SJ. Ethical considerations concerning treatment allocation in drug development trials. Stat Methods Med Res 2002; 11: 403–11.
3. Senn SJ. The misunderstood placebo. Appl Clin Trials 2001; 10: 40–46.
4. Rawls J. A theory of justice. Oxford: Oxford University Press, 1972.
5. Chalmers I, Silverman WA. Professional and public double standards on clinical experimentation. Control Clin Trials 1987; 8: 388–91.